Concepedia

Lisa H. Liu

LH

Statistics

Publications

4

Citations

241

H-Index

4

Active since

2004

Affiliations

Boehringer Ingelheim (United States)(Current)

Johnson & Johnson (United States)

Boehringer Ingelheim (Germany)

Sanford Burnham Prebys Medical Discovery Institute

Lisa H. Liu is an author at Boehringer Ingelheim (United States) specializing in medicinal chemistry, kinase inhibitors, and enzyme inhibition.

Publications per year

2004–2008

4

Publications

4

Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth

Zizheng Dong, Lisa H. Liu, Baoguang Han et al. · Oncogene · 2004 · 121 citations

, , +12

Discovery of potent and selective PKC-θ inhibitors

Charles L. Cywin, Georg Dahmann, Anthony S. Prokopowicz et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 70 citations · Full text

, , +12

Itk kinase inhibitors: Initial efforts to improve the metabolical stability and the cell activity of the benzimidazole lead

K.J.M. Moriarty, Michael P. Winters, Lei Qiao et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 26 citations · Full text

, , +13

5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk)

Michael P. Winters, Darius Robinson, Hnin Hnin Khine et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 24 citations · Full text

, , +7

1–4 of 4